Key Dates
- Board meeting scheduled: Tuesday, November 3, 2026
- Trading window closure period: October 1, 2026 to November 5, 2026 (close of trading hours)
Meeting Agenda
The Board of Directors of Anthem Biosciences Limited will consider and approve:
- Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026
- Unaudited Consolidated Financial Results for the quarter and half year ended September 30, 2026
Regulatory Compliance Details
- Filed under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Trading window closure implemented in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015
- Trading window remains closed until 48 hours after declaration of financial results
- Continuation of previous trading restriction communicated via letter dated September 24, 2026